XML 53 R10.htm IDEA: XBRL DOCUMENT
v3.24.3

Revenue Recognition | 9 Months Ended
--- | ---
Sep. 28, 2024
Revenue from Contract with Customer [Abstract] |
Revenue Recognition | REVENUE RECOGNITION The following is a summary of our net sales by category (in millions):
| Three Months Ended |  | Nine Months Ended
| September 28, 2024 |  | September 30, 2023 |  | September 28, 2024 |  | September 30, 2023
CSCA(1) |  |  |  |  |  |  |
Nutrition | $ | 127.1 |  |  | $ | 129.7 |  |  | $ | 303.8 |  |  | $ | 436.3 |
Upper Respiratory | 120.9 |  |  | 131.2 |  |  | 370.0 |  |  | 422.2 |
Digestive Health | 113.5 |  |  | 118.1 |  |  | 361.7 |  |  | 368.2 |
Pain and Sleep-Aids | 87.7 |  |  | 94.5 |  |  | 251.9 |  |  | 294.6 |
Healthy Lifestyle | 80.9 |  |  | 79.4 |  |  | 221.3 |  |  | 219.3 |
Oral Care | 66.9 |  |  | 76.7 |  |  | 204.8 |  |  | 235.5 |
Skin Care | 51.9 |  |  | 58.2 |  |  | 158.6 |  |  | 189.8 |
Women's Health | 18.0 |  |  | 10.5 |  |  | 62.0 |  |  | 35.6 |
Vitamins, Minerals, and Supplements ("VMS") | 3.5 |  |  | 4.4 |  |  | 13.0 |  |  | 13.9 |
Other CSCA | 0.9 |  |  | 0.8 |  |  | 2.4 |  |  | 2.5 |
Total CSCA | $ | 671.3 |  |  | $ | 703.5 |  |  | $ | 1,949.5 |  |  | $ | 2,217.9 |
CSCI |  |  |  |  |  |  |
Skin Care | $ | 91.0 |  |  | $ | 86.7 |  |  | $ | 333.5 |  |  | $ | 293.1 |
Upper Respiratory | 86.1 |  |  | 78.2 |  |  | 206.0 |  |  | 227.9 |
Pain and Sleep-Aids | 56.9 |  |  | 61.1 |  |  | 158.6 |  |  | 163.8 |
Healthy Lifestyle | 53.2 |  |  | 52.4 |  |  | 175.2 |  |  | 179.4 |
VMS | 43.0 |  |  | 46.1 |  |  | 127.4 |  |  | 135.4 |
Women's Health | 32.2 |  |  | 28.5 |  |  | 101.2 |  |  | 89.5 |
Oral Care | 23.3 |  |  | 24.8 |  |  | 75.0 |  |  | 75.5 |
Digestive Health | 9.0 |  |  | 10.8 |  |  | 27.0 |  |  | 30.0 |
Other CSCI(2) | 21.6 |  |  | 31.7 |  |  | 81.5 |  |  | 86.1 |
Total CSCI | 416.3 |  |  | 420.3 |  |  | 1,285.5 |  |  | 1,280.7 |
Total net sales | $ | 1,087.5 |  |  | $ | 1,123.8 |  |  | $ | 3,235.1 |  |  | $ | 3,498.7 |
(1) We updated our global reporting product categories as a result of legacy sales being moved out of Other CSCA and into respective categories. These product categories have been adjusted retroactively to reflect the changes and have no impact on historical financial position, results of operations, or cash flows. (2) Consists primarily of the Rare Diseases Business and other miscellaneous or otherwise uncategorized product lines and other adjustments, none of which is greater than 10% of the segment net sales. The following table provides information about contract assets from contracts with customers (in millions):
| Balance Sheet Location |  | September 28, 2024 |  | December 31, 2023
Short-term contract assets | Prepaid expenses and other current assets |  | $ | 27.4 |  |  | $ | 28.5 |
We generated net sales in the following geographic locations(1) (in millions):
| Three Months Ended |  | Nine Months Ended
| September 28, 2024 |  | September 30, 2023 |  | September 28, 2024 |  | September 30, 2023
U.S. | $ | 656.9 |  |  | $ | 690.3 |  |  | $ | 1,917.1 |  |  | $ | 2,176.3 |
Europe(2) | 397.3 |  |  | 399.8 |  |  | 1,225.5 |  |  | 1,232.6 |
All other countries(3) | 33.3 |  |  | 33.7 |  |  | 92.5 |  |  | 89.8 |
Total net sales | $ | 1,087.5 |  |  | $ | 1,123.8 |  |  | $ | 3,235.1 |  |  | $ | 3,498.7 |
(1) The net sales by geography are derived from the location of the entity that sells to a third party. (2) Includes Ireland net sales of $11.1 million and $26.8 million for the three and nine months ended September 28, 2024, and $11.9 million and $31.0 million for the three and nine months ended September 30, 2023. (3) Includes net sales generated primarily in Australia and Canada.

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-9 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-10 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-15 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-12 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-13 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Name Accounting Standards Codification -Topic 606 -Publisher FASB -URI https://asc.fasb.org/606/tableOfContent + Details
Name: | us-gaap_RevenueFromContractWithCustomerTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration